ArticleJournal of ovarian research2023

Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma.

Zheng Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.